ACL Repair, Bankart Repair, Meniscectomy
Conditions
Keywords
pain control, intra-articular pain control device, ACL repair, Bankart Repair
Brief summary
The aim of this study is to determine whether the continuous intraarticular infusion of local anesthetics in the postoperative period can improve analgesia and patients satisfaction after knee and shoulder arthroscopy.
Detailed description
We propose to evaluate the long-term efficacy of the continuous intraarticular delivery of local anesthetics via a disposable, self-regulated DonJoy Pain Control infusion pump. Patients will be randomly assigned to receive either an intra-articular infusion of bupivacaine 0.125%, or saline delivered at a rate of 5 ml/hr for 48 hours by a DonJoy® Pain Control infusion pump. Patients will receive a femoral block (FNB) and a sciatic block (SNB) for knee arthroscopy or an interscalene block (INB) for shoulder arthroscopy prior to surgery. After the operation, patients will receive morphine via a Patient Controlled Analgesia (PCA) pump for pain control. The patient will be admitted overnight to a Care Unit, with the PCA discontinued at discharge or 24 hours, whichever is earlier. If clinically indicated, the PCA may be extended at the discretion of the pain team. Upon discharge and during the 48 hour study period the patient will receive oral oxycodone and acetaminophen. The patient and their family will remove the DonJoy® Pain Control infusion pump 48 hours after the surgery.
Interventions
DRUGBupivacaine
Patients receive either normal saline or Bupivacaine in normal saline that infuses intraarticularly for 48 hours.
Sponsors
Children's Anesthesiology Associates, Ltd.
Children's Hospital of Philadelphia
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)
Eligibility
Sex/Gender
ALL
Age
11 Years to 19 Years
Healthy volunteers
No
Inclusion criteria
* Children between the ages of 11 and 19 years old. * Knee and shoulder arthroscopy procedures
Exclusion criteria
* Contraindications to Femoral-Interscalene Nerve Block * Conditions that affect the proper evaluation of pain and side effects. * Intake of NSAIDs or opioids in the 12 hours prior to the operation * Allergy to study medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the total amount of opioids and other analgesic medications consumed in the recovery room and during the 48 hour study period (intravenous and oral). | 48 hour post operatively |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints will include the incidence of side effects, such as nausea, vomiting, sedation and itching, pain scores at defined time periods and patients' satisfaction. | 48 hours post operatively |
Countries
United States
Outcome results
None listed